NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo

• Published in: Human gene therapy Vol. 22; no. 9; p. 1071
• Main Authors: Suzuki, Masataka, Cela, Racel, Bertin, Terry K, Sule, Gautam, Cerullo, Vincenzo, Rodgers, John R, Lee, Brendan
• Format: Journal Article
• Language: English
• Published: United States 01.09.2011
• Subjects: Adenoviridae - genetics; Adenoviridae - immunology; Animals; Epigenomics; Gene Expression Regulation; Genetic Vectors - administration & dosage; Genetic Vectors - immunology; Helper Viruses - genetics; Immunity, Innate - genetics; Inflammation - immunology; Liver - immunology; Liver - metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88 - genetics; Myeloid Differentiation Factor 88 - metabolism; Nod2 Signaling Adaptor Protein - genetics; Nod2 Signaling Adaptor Protein - metabolism; RNA, Messenger; Signal Transduction; Transgenes
• ISSN: 1557-7422
• DOI: 10.1089/hum.2011.002

We previously demonstrated that Toll-like receptor/myeloid differentiation primary response gene 88 (MyD88) signaling is required for maximal innate and acquired [T helper cell type 1 (Th1)] immune responses following systemic administration of helper-dependent adenoviral vectors (HDAds). However, MyD88-deficient mice injected with HDAdLacZ exhibited only partial reduction of innate immune cytokine expression compared with wild-type mice, suggesting MyD88-independent pathways also respond to HDAds. We now show that NOD2, a nucleotide-binding and oligomerization domain (NOD)-like receptor known to detect muramyl dipeptides in bacterial peptidoglycans, also contributes to innate responses to HDAds, but not to humoral or Th1 immune responses. We established NOD2/MyD88 double-deficient mice that, when challenged with HDAds, showed a significant reduction of the innate response compared with mice deficient for either gene singly, suggesting that NOD2 signaling contributes to the innate response independently of MyD88 signaling following systemic administration of HDAds. In addition, NOD2-deficient mice exhibited significantly higher transgene expression than did wild-type mice at an early time point (before development of an acquired response), but not at a later time point (after development of an acquired response). These results indicate that the intracellular sensor NOD2 is required for innate responses to HDAds and can limit transgene expression during early phases of infection.